Trials Say Start ARNI in Hospital in HF, 'Below Normal' LVEF
Filling an evidence gap, a pooled analysis of patients with heart failure 'across the LVEF spectrum' supports starting sacubitril-valsartan in the hospital.
Source: medscape.com
Page 37 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Adverse Effects Today - Breaking & Trending Today
Patients With Psoriasis Lose Weight With Roflumilast: Study
Oral roflumilast not only appears to improve skin symptoms, but it could also help with weight loss, results of the phase 2 PSORRO study suggest.
Source: medscape.com
EMA Warns That Omega-3-Acid Ethyl Esters May Cause AF
Atrial fibrillation will now be included as a common side effect in the Summary of Product Characteristics for medicinal products containing omega-3-acid ethyl esters.
Source: medscape.com
FDA Approves New Drug for Ulcerative Colitis
Etrasimod is the second oral sphingosine-1-phosphate (S1P) receptor approved in the US for treating moderate to severe active ulcerative colitis in adults.
Source: medscape.com
New Drug Promising for Resistant Focal Epilepsy
A novel investigational antiseizure medication reduces seizure frequency by more than 50% in some patients with treatment-resistant focal epilepsy.
Source: medscape.com